Pak Fah Yeow International Limited (HKG:0239)
Hong Kong · Delayed Price · Currency is HKD 2.400
+0.010 (0.42%)
Apr 2, 2026, 3:58 PM HKT
HKG:0239 Revenue
In the year 2025, Pak Fah Yeow International had annual revenue of 214.28M HKD, down -9.75%. Pak Fah Yeow International had revenue of 119.32M in the half year ending December 31, 2025, a decrease of -10.25%.
Revenue
214.28M
Revenue Growth
-9.75%
P/S Ratio
3.49
Revenue / Employee
2.14M
Employees
100
Market Cap
747.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 214.28M | -23.15M | -9.75% |
| Dec 31, 2024 | 237.43M | -22.13M | -8.53% |
| Dec 31, 2023 | 259.56M | 111.81M | 75.68% |
| Dec 31, 2022 | 147.75M | 7.22M | 5.14% |
| Dec 31, 2021 | 140.53M | 30.77M | 28.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 4.17B |
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Essex Bio-Technology | 1.81B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| JBM (Healthcare) | 812.98M |
| Wai Yuen Tong Medicine Holdings | 721.27M |